Basic Information
LncRNA/CircRNA Name | circ_0001258 |
Synonyms | |
Region | |
Ensemble | |
Refseq |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | Osteosarcoma |
ICD-0-3 | NA |
Methods | RNA-seq, qPCR, luciferase reporter assay, RIP |
Sample | OS cell lines |
Expression Pattern | differential expressed |
Function Description | In addition, two constructed ceRNA regulatory pathways, lncRNAMEG3/hsa-miR-200b-3p/AKT2 and hsa_circ_0001258/hsa-miR-744-3p/GSTM2, were randomly selected and validated by real-time qPCR, RNA immunoprecipitation (RIP), RNA pull-down assay, and dual luciferase reporter gene system. |
Pubmed ID | 30692017 |
Year | 2019 |
Title | Analyzing the Interactions of mRNAs and ncRNAs to Predict Competing Endogenous RNA Networks in Osteosarcoma Chemo-Resistance. |
External Links
Links for circ_0001258 | GenBank HGNC NONCODE |
Links for Osteosarcoma | OMIM COSMIC |